Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.

http://www.wikidata.org/entity/Q31137356

about

Bariatric surgery and obesity: influence on the incretins β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes.Glucose homeostasis during short-term and prolonged exposure to high altitudes.The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes.Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.The safety of albiglutide for the treatment of type 2 diabetes.GLP-1 response to sequential mixed meals: influence of insulin resistance.Type 2 diabetes mellitus

P2860

Q33838154-164FEFE0-4B93-437A-A904-84797EE889EA Q34393402-C92B6846-EAA6-4E43-9F10-6C4FA7FB00A6 Q35441680-FA5EABB4-D176-43DB-85BF-EC69C565E73E Q36902183-A93BEC81-3BB6-4F64-86AD-9DD90426A7BB Q37692849-C8E40472-9345-433C-9144-2992AD29706E Q39047697-59117D15-2EE4-44F0-B124-702BB63FD788 Q39415439-368D106D-1DA2-4095-B608-3152CF28617A Q47621594-443D047F-6C88-4C9C-88E1-BC441F545CBD Q58447602-6C65FEDF-80D0-4B55-80E7-4C20D79727B6

P2860

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.

http://www.wikidata.org/entity/Q31137356

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Mechanisms of the incretin eff ...... patients with type 2 diabetes.

@ast

Mechanisms of the incretin eff ...... patients with type 2 diabetes.

@en

type

label

Mechanisms of the incretin eff ...... patients with type 2 diabetes.

@ast

Mechanisms of the incretin eff ...... patients with type 2 diabetes.

@en

prefLabel

Mechanisms of the incretin eff ...... patients with type 2 diabetes.

@ast

Mechanisms of the incretin eff ...... patients with type 2 diabetes.

@en

P1433

Q31137356-FAF1EC0A-FFB7-4E3C-A1CD-1816CB79D8A3

P1476

Q31137356-4242187E-919F-49C3-84DF-21B5D361CA53

P2093

Q31137356-0395C214-D64A-4D3E-A8AD-490F3C3A0906

Q31137356-64451486-8CB2-4507-A421-678239C8CE89

Q31137356-671C7CCB-75D9-433F-A161-7EBA0B0FAE3C

P2860

Q31137356-1D48B140-4E95-4E6D-809C-583A9A407F5D

Q31137356-237A453E-D9DE-4218-AAEA-C4D30E18EF8E

Q31137356-51B7F627-FE5F-496C-923A-E77EEB1E6E26

Q31137356-60BF6EAC-5BE6-4BCE-BF95-D77FACB5D461

Q31137356-627B1795-FE97-4206-A3DA-638C81989FAF

Q31137356-63BAD4FF-379F-475F-8D02-B51E20C64F94

Q31137356-6DF48DD5-042E-45A2-B80E-BB35B1DA0536

Q31137356-7D9C06D6-4A3D-4038-934E-BA7C36A9D8A1

Q31137356-96C00636-5354-4755-864F-799B9BC93F99

Q31137356-ADDD4ED5-B460-44EA-8E4C-3BDAD0E9D378

P304

Q31137356-956D3080-8429-4BDF-9FFA-5BF079DD8E9B

P31

Q31137356-8CFE4BC8-0F0F-4FC0-805D-9E0B9D0F2143

P356

Q31137356-4A875AC6-DA18-4801-BC33-8507A0DCCDF7

P407

Q31137356-E639560E-69E7-4A37-8F82-15174621FC9A

P433

Q31137356-C73B5F28-436F-4208-A61E-EE5BD26E410C

P478

Q31137356-6BBFC231-EFEE-4252-B8B2-EB691BCD3118

P50

Q31137356-007F38B5-BB9D-4A89-8D51-0DAC26556B80

Q31137356-AF97B8DC-95FC-4D4D-B601-014932E301E1

Q31137356-BD2639C5-8C23-499A-A936-EF11709D88B5

P577

Q31137356-F7F15718-638B-45CD-A2DB-CA9E101AEA52

P5875

Q31137356-A055BA13-58F9-4900-B3C0-A4A211A3D13B

P698

Q31137356-4E1F301B-3DED-40D5-BA7E-1C4C8D7544FB

P921

Q31137356-A867DF67-D161-4466-B753-03175F371DFC

P932

Q31137356-60961505-C36B-4DD5-839C-30BF81113B98

P356

JOURNAL.PONE.0073154

P1433

P1476

Mechanisms of the incretin eff ...... patients with type 2 diabetes.

@en

P2093

Andrea Mari

http://www.w3.org/2001/XMLSchema#string

Ele Ferrannini

http://www.w3.org/2001/XMLSchema#string

Filip K Knop

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.

Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Beta-cell function assessment from modelling of oral tests: an effective approach.

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.

Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.

Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance.

Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus.

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.

Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation.

P304

e73154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0073154

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Jens Juul Holst

Jonatan Ising Bagger

P577

2013-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256477753

http://www.w3.org/2001/XMLSchema#string

P698

24019903

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3760909

http://www.w3.org/2001/XMLSchema#string